Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Avatrombopag is a new oral thrombopoietin receptor agonist, which has been widely used in clinical practice to increase platelet count, and its therapeutic effect has attracted muc···【more】
Article source：Captain MedicineRelease date：2025-01-21Recommended：241
Avatrombopag is a novel thrombopoietin receptor agonist, which has attracted much attention in clinical application.What is the dosage of avatrombopagKnowing the correct dosage of ···【more】
Article source：Captain MedicineRelease date：2025-01-21Recommended：190
Avatrombopag is a new type of drug, and its correct use is critical to the patient's treatment outcome.How to use avatrombopagKnowing the correct way to use avatrombopag can he···【more】
Article source：Captain MedicineRelease date：2025-01-20Recommended：156
Avatrombopag is a novel oral thrombopoietin receptor agonist, and its dosage has attracted much attention.What is the recommended dosage of avatrombopag?Knowing the correct dosage ···【more】
Article source：Captain MedicineRelease date：2025-01-20Recommended：235
Avatrombopag is a novel oral thrombopoietin receptor agonist that has demonstrated significant efficacy in clinical application and provides a new treatment option for specific pat···【more】
Article source：Captain MedicineRelease date：2025-01-17Recommended：257
Avatrombopag is an innovative drug that plays an important role in clinical treatment, especially for patients with specific diseases.What diseases is avatrombopag suitable for?Ava···【more】
Article source：Captain MedicineRelease date：2025-01-17Recommended：254
Avatrombopag is a novel drug that has demonstrated unique therapeutic potential in specific medical areas.What are the indications for avatrombopagExploring the indications for ava···【more】
Article source：Captain MedicineRelease date：2025-01-17Recommended：219
Avatrombopag is a novel drug that has demonstrated unique therapeutic potential in specific medical areas.What are the indications for avatrombopagExploring the indications for ava···【more】
Article source：Captain MedicineRelease date：2025-01-16Recommended：304
Avatrombopag is a drug for the treatment of thrombocytopenia, and its price and accessibility have attracted much attention from patients.Is avatrombopag expensive? How much is a b···【more】
Article source：Captain MedicineRelease date：2025-01-16Recommended：223
Avatrombopag is a drug used to treat thrombocytopenia associated with chronic liver disease, and its price dynamics have been of great concern to patients. This article will take a···【more】
Article source：Captain MedicineRelease date：2025-01-15Recommended：268
Avatrombopag is a drug used to treat chronic liver disease and chronic immune thrombocytopenia, and its price has been a focus for patients and the medical community. This article ···【more】
Article source：Captain MedicineRelease date：2025-01-15Recommended：257
Dabrafenib is a drug used to treat specific types of skin cancer, such as melanoma, and precautions during its use are important for patients.What are the precautions for using dab···【more】
Article source：Captain MedicineRelease date：2025-01-14Recommended：234
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：1702025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：4092024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：1662025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：1852025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：1642025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：2002025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：1812025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：1732025-27-11
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
